En esta página
NKTX Nkarta, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$2,58
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,70mínimo 52 semanas
$3,72máximo 52 semanas
Capitalización Bursátil
$183M
P/E
-1.8
BPA
$-1.41
Ingresos
$0
tus insignias
Rango 52S
$2–$4
Calificación del Analista
BUY
Precio Objetivo
$11
P/E
-1.8
ROE
-31.1%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
NKTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.58
Capitalización Bursátil
$183M
P/E
-1.8
BPA
$-1.41
Ingresos
$0
ROE
-31.1%
Rango 52S
$2–$4
NKTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02019-12-31 → 2025-12-31
BPA$-1.412021-12-31 → 2025-12-31
Flujo de caja libre$-90M2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | NKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.8promedio 5A ≈-2.8 | ≈-2.8 | · | · | |
| P/B (P/C) | 0.6promedio 5A ≈1.0 | ≈1.0 | 3.6 | Infravalorado | |
| Price / FCF (Precio / FCF) | -2.0promedio 5A ≈-3.1 | ≈-3.1 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -2.1promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.6promedio 5A ≈1.0 | ≈1.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | NKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -23.0%promedio 5A ≈-26.8% | ≈-26.8% | -31.6% | De primer nivel | |
| ROE | -31.1%promedio 5A ≈-32.2% | ≈-32.2% | -70.9% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | NKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 8.0promedio 5A ≈14.7 | ≈14.7 | 7.9 | En línea | |
| Quick Ratio (Ratio Rápido) | 12.4promedio 5A ≈14.3 | ≈14.3 | 6.3 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | NKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.1 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.1%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.54 | $-0.38 | -40.8% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.37 | $-0.38 | 2.6% |
| 31 de diciembre de 2025 | $-0.37 | $-0.32 | -14.1% | |
| 30 de septiembre de 2025 | $-0.29 | $-0.32 | 9.3% | |
| 30 de junio de 2025 | $-0.31 | $-0.36 | 14.4% | |
| 31 de marzo de 2025 | $-0.43 | $-0.45 | 4.2% | |
| 31 de diciembre de 2024 | $-0.35 | $-0.42 | 16.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | $0 | · | $115.0K | |
| R&D Expense | $90M | $97M | $97M | $91M | $63M | $36M | $17M | |
| SG&A Expense | $32M | $31M | $35M | $28M | $23M | $15M | $5M | |
| Operating Expenses | $122M | $128M | $132M | $119M | $86M | $52M | $22M | |
| Operating Income | $-122M | $-128M | $-132M | $-119M | $-86M | $-52M | $-22M | |
| Other Non-op | $2M | $87.0K | $42.0K | $-470.0K | $-16.0K | $-3.0K | $18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | $-21M | |
| EPS (Basic) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| EPS (Diluted) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| Shares (Basic) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| Shares (Diluted) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| EBITDA | $-113M | $-119M | $-126M | $-116M | $-85M | $-51M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $28M | $31M | $37M | $61M | $97M | $21M | |
| Short-term Investments | $237M | $239M | $217M | $315M | $177M | $218M | $16M | |
| Prepaid Expense | $6M | $6M | $5M | $9M | $8M | $4M | $474.0K | |
| Other Current Assets | $2M | $3M | $2M | $3M | $3M | $1M | $67.0K | |
| Current Assets | $283M | $273M | $253M | $361M | $246M | $319M | $37M | |
| PP&E (Net) | $67M | $75M | $79M | $62M | $13M | $9M | $3M | |
| PP&E (Gross) | $96M | $96M | $91M | $68M | $16M | $11M | $4M | |
| Accum. Depreciation | $29M | $21M | $12M | $6M | $3M | $1M | $645.0K | |
| Other Non-current Assets | $2M | $4M | $4M | $2M | $1M | $547.0K | $455.0K | |
| Total Assets | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Accounts Payable | $2M | $638.0K | $4M | $2M | $1M | $1M | $2M | |
| Accrued Liabilities | $13M | $12M | $14M | $16M | $9M | $6M | $3M | |
| Current Liabilities | $22M | $19M | $23M | $22M | $13M | $9M | $8M | |
| Capital Leases | $70M | $74M | $82M | $79M | $10M | $8M | $6M | |
| Other Non-current Liabilities | $87.0K | $87.0K | · | · | $18.0K | $82.0K | $134.0K | |
| Total Liabilities | $92M | $93M | $106M | $101M | $23M | $16M | $14M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-648M | $-544M | $-435M | $-318M | $-204M | $-118M | $-27M | |
| AOCI | $407.0K | $674.0K | $8.0K | $-679.0K | $-150.0K | $3.0K | $-2.0K | |
| Stockholders' Equity | $312M | $408M | $273M | $372M | $251M | $321M | $-25M | |
| Liabilities + Equity | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Shares Outstanding | 71,078,531 | 70,645,139 | 49,181,295 | 48,877,806 | 32,971,107 | 32,627,963 | 1,600,601 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $9M | $6M | $3M | $2M | $800.0K | $400.0K | |
| Stock-based Comp | $9M | $17M | $17M | $17M | $14M | $7M | $947.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-2M | $-17M | $8M | $37M | $2M | $40M | · | |
| Operating Cash Flow | $-89M | $-100M | $-86M | $-57M | $-68M | $-44M | $-18M | |
| CapEx | $1M | $4M | $28M | $47M | $5M | $8M | $2M | |
| Investing Cash Flow | $100M | $-130M | $79M | $-185M | $33M | $-210M | $-18M | |
| Financing Cash Flow | $141.0K | $226M | $691.0K | $219M | $1M | $330M | $50M | |
| Net Change in Cash | $12M | $-3M | $-6M | $-23M | $-34M | $76M | $13M | |
| Free Cash Flow | $-90M | $-104M | $-114M | $-104M | $-73M | $-51M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -23.0% | -24.7% | -27.6% | -30.5% | -28.1% | -47.3% | · | |
| ROE | -31.1% | -25.9% | -41.2% | -29.5% | -33.0% | -27.9% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 | 36.1 | · | |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 | 35.7 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.39 | $5.78 | $5.56 | $7.62 | $7.61 | $9.84 | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | |
| Cash Flow / Share | $-1.20 | $-1.47 | $-1.76 | $-1.31 | · | · | · | |
| Cash / Share | $0.56 | $0.39 | $0.63 | $0.77 | $1.84 | $2.96 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | |
| EPS (TTM) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | · | $0 | · | · | |
| Net Income TTM | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | · | |
| Market Cap | $131M | $176M | $325M | $293M | $506M | $2.01B | · | |
| P/E | -1.3 | -1.6 | -2.8 | -2.3 | -5.9 | · | · | |
| P/B | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Tangible Book | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Cash Flow | -1.5 | -1.8 | -3.8 | -5.1 | -7.5 | -46.1 | · | |
| P / FCF | -1.5 | -1.7 | -2.8 | -2.8 | -6.9 | -39.3 | · | |
| Earnings Yield | -76.2% | -64.3% | -36.4% | -43.6% | -17.1% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $25M | $25M | $20M | $21M | $24M | $23M | $25M | $23M | $25M | $23M | $22M | $25M | $26M | $27M | $23M | |
| SG&A Expense | $14M | $6M | $6M | $7M | $6M | $12M | $8M | $9M | $8M | $8M | $8M | $7M | $12M | $8M | $8M | $7M | |
| Operating Expenses | $43M | $31M | $31M | $27M | $27M | $37M | $31M | $34M | $31M | $33M | $31M | $29M | $37M | $34M | $35M | $30M | |
| Operating Income | $-43M | $-31M | $-31M | $-27M | $-27M | $-37M | $-31M | $-34M | $-31M | $-33M | $-31M | $-29M | $-37M | $-34M | $-35M | $-30M | |
| Other Non-op | $222.0K | $206.0K | $256.0K | $2M | $239.0K | $205.0K | $94.0K | $-3.0K | $-2.0K | $-2.0K | $-25.0K | $33.0K | $1.0K | $33.0K | $-489.0K | $17.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-28M | $-27M | $-22M | $-23M | $-32M | $-26M | $-28M | $-25M | $-30M | $-28M | $-26M | $-33M | $-31M | $-33M | $-28M | |
| EPS (Basic) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| Shares (Basic) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| Shares (Diluted) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| EBITDA | $-40M | $-29M | · | $-25M | $-25M | $-34M | · | $-31M | $-28M | $-30M | · | $-27M | $-36M | $-34M | · | $-30M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $40M | $60M | $53M | $53M | $28M | $57M | $120M | $250M | $31M | $38M | $29M | $54M | $37M | $40M | |
| Short-term Investments | $158M | $203M | $237M | $222M | $236M | $213M | $239M | $226M | $204M | $187M | $217M | $237M | $252M | $270M | $315M | $353M | |
| Prepaid Expense | $5M | $5M | $6M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $6M | $6M | $9M | $9M | $9M | |
| Other Current Assets | · | · | $2M | · | · | · | $3M | · | · | · | $2M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $188M | $236M | $283M | $289M | $297M | $272M | $273M | $290M | $332M | $443M | $253M | $281M | $287M | $332M | $361M | $401M | |
| PP&E (Net) | $57M | $64M | $67M | $68M | $70M | $73M | $75M | $76M | $78M | $79M | $79M | $78M | $76M | $70M | $62M | $30M | |
| PP&E (Gross) | $93M | $96M | $96M | $96M | $96M | $96M | $96M | $95M | $94M | $92M | $91M | $87M | $84M | $76M | $68M | $35M | |
| Accum. Depreciation | $36M | $31M | $29M | $28M | $25M | $23M | $21M | $19M | $16M | $14M | $12M | $9M | $7M | $7M | $6M | $5M | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $2M | |
| Total Assets | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Accounts Payable | $4M | $2M | $2M | $1M | $2M | $1M | $638.0K | $2M | $4M | $3M | $4M | $4M | $3M | $5M | $2M | $9M | |
| Accrued Liabilities | $12M | $10M | $13M | $11M | $11M | $11M | $12M | $14M | $12M | $13M | $14M | $15M | $18M | $15M | $16M | $12M | |
| Current Liabilities | $24M | $18M | $22M | $19M | $19M | $19M | $19M | $22M | $21M | $22M | $23M | $26M | $27M | $26M | $22M | $26M | |
| Capital Leases | $66M | $68M | $70M | $70M | $72M | $73M | $74M | $79M | $80M | $81M | $82M | $83M | $84M | $86M | $79M | $78M | |
| Other Non-current Liabilities | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | · | · | · | · | · | · | · | · | $5.0K | |
| Total Liabilities | $90M | $86M | $92M | $89M | $91M | $92M | $93M | $101M | $101M | $103M | $106M | $109M | $111M | $112M | $101M | $105M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-717M | $-676M | $-648M | $-621M | $-599M | $-576M | $-544M | $-518M | $-490M | $-465M | $-435M | $-408M | $-382M | $-349M | $-318M | $-285M | |
| AOCI | $-425.0K | $-130.0K | $407.0K | $536.0K | $362.0K | $652.0K | $674.0K | $2M | $-263.0K | $-127.0K | $8.0K | $-409.0K | $-601.0K | $-174.0K | $-679.0K | $-1M | |
| Stockholders' Equity | $248M | $286M | $312M | $338M | $358M | $379M | $408M | $431M | $453M | $474M | $273M | $297M | $318M | $347M | $372M | $399M | |
| Liabilities + Equity | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Shares Outstanding | · | · | 71,078,531 | · | · | · | 70,645,139 | · | · | · | 49,181,295 | · | · | · | 48,877,806 | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $800.0K | $700.0K | $700.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | |
| Restructuring | · | · | $-59.0K | $-26.0K | $-86.0K | $5M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-24M | $-28M | $-22M | $-19M | $-19M | $-30M | $-25M | $-25M | $-22M | $-29M | $-23M | $-20M | $-22M | $-21M | $-7M | $-15M | |
| CapEx | $183.0K | $413.0K | $560.0K | $-8.0K | $138.0K | $518.0K | $1M | $777.0K | $2M | $175.0K | $7M | $6M | $10M | $5M | $35M | $8M | |
| Investing Cash Flow | $21M | $16M | $1M | $25M | $19M | $54M | $-5M | $-39M | $-108M | $21M | $16M | $29M | $-3M | $37M | $5M | $-79M | |
| Financing Cash Flow | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K | $-368.0K | $226M | $295.0K | $0 | $395.0K | $1.0K | $424.0K | $3M | |
| Net Change in Cash | $-2M | $-12M | $-20M | $7M | $816.0K | $25M | $-29M | $-63M | $-130M | $219M | $-7M | $9M | $-25M | $16M | $-2M | $-91M | |
| Free Cash Flow | · | $-29M | · | · | · | $-30M | · | · | · | $-29M | · | · | · | $-26M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -6.6% | · | -4.5% | -4.6% | -6.1% | · | -6.0% | -5.1% | -5.7% | · | -5.6% | -7.1% | -8.1% | · | -7.1% | |
| ROE | -13.3% | -8.4% | · | -5.7% | -5.7% | -7.5% | · | -7.8% | -6.5% | -7.2% | · | -7.4% | -9.0% | -10.7% | · | -8.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 13.0 | · | 15.2 | 15.7 | 14.5 | · | 12.9 | 15.9 | 20.0 | · | 11.0 | 10.8 | 12.8 | · | 15.2 | |
| Quick Ratio | 7.8 | 12.7 | · | 14.9 | 15.3 | 14.2 | · | 12.6 | 15.6 | 19.7 | · | 10.7 | 10.5 | 12.4 | · | 14.8 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.40 | · | · | · | $-0.56 | · | · | · | $-0.42 | · | · | |
| EPS (TTM) | $-1.58 | $-1.35 | · | $-1.32 | $-1.42 | $-1.45 | · | $-1.88 | $-2.01 | $-2.35 | · | $-2.46 | $-2.52 | $-2.45 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-117M | $-100M | · | $-103M | $-109M | $-111M | · | $-111M | $-108M | $-116M | · | $-122M | $-125M | $-119M | · | · | |
| P/E | -1.8 | -1.6 | · | -1.6 | -1.2 | -1.3 | · | -2.4 | -2.9 | -4.6 | · | -0.6 | -0.9 | -1.4 | · | · | |
| Earnings Yield | -55.8% | -64.0% | · | -63.8% | -85.5% | -78.8% | · | -41.6% | -34.0% | -21.7% | · | -177.0% | -115.1% | -69.0% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $0 | · | · | $0 |
| Beneficio neto | $-104M | $-109M | $-118M | $-114M | $-86M |
| EPS Diluido | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 |
| Ratio Rápido | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-90M | $-104M | $-114M | $-104M | $-73M |
Propietarios institucionales (13F) 146 declarantes · $167.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
146
Valor en tenencia
$167.8M
Nuevas posiciones
27
Posiciones cerradas
13
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 27 (+5 vs trimestre anterior) | 13 (+4 vs trimestre anterior) | 51 (+4 vs trimestre anterior) | 37 (+6 vs trimestre anterior) | +230K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $30 578 515 | 10 805 129 | 18,23% | Acciones |
| BlackRock, Inc. | $17 829 600 | 6 300 212 | 10,63% | Acciones |
| NEA Management Company, LLC | $10 099 650 | 3 568 781 | 6,02% | Acciones |
| SAMSARA BIOCAPITAL, LLC | $9 926 695 | 3 507 666 | 5,92% | Acciones |
| SR One Capital Management, LP | $9 433 332 | 3 333 333 | 5,62% | Acciones |
| GSK plc | $8 916 572 | 3 150 732 | 5,32% | Acciones |
| Monaco Asset Management SAM | $6 716 722 | 2 373 400 | 4,00% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 300 754 | 2 226 415 | 3,76% | Acciones |
| CITADEL ADVISORS LLC | $6 154 528 | 2 174 745 | 3,67% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $5 301 419 | 1 873 293 | 3,16% | Acciones |
| VANGUARD GROUP INC | $4 805 134 | 2 597 370 | 2,86% | Acciones |
| STATE STREET CORP | $3 639 688 | 1 286 109 | 2,17% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 638 743 | 1 285 507 | 2,17% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $3 332 755 | 1 177 652 | 1,99% | Acciones |
| WASATCH ADVISORS LP | $3 329 257 | 1 577 847 | 1,98% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $2 983 530 | 1 054 251 | 1,78% | Acciones |
| AWM Investment Company, Inc. | $2 563 980 | 906 000 | 1,53% | Acciones |
| Blackstone Inc. | $2 114 135 | 747 044 | 1,26% | Acciones |
| MARSHALL WACE, LLP | $1 904 620 | 673 010 | 1,14% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $1 650 595 | 583 249 | 0,98% | Acciones |
| JPMORGAN CHASE & CO | $1 604 493 | 562 980 | 0,96% | Acciones |
| Peapod Lane Capital LLC | $1 556 282 | 549 923 | 0,93% | Acciones |
| Alyeska Investment Group, L.P. | $1 372 097 | 484 840 | 0,82% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 367 703 | 483 211 | 0,82% | Acciones |
| Nuveen, LLC | $1 328 840 | 469 555 | 0,79% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 228 169 | 433 982 | 0,73% | Acciones |
| TWO SIGMA ADVISERS, LP | $1 197 320 | 647 200 | 0,71% | Acciones |
| NORTHERN TRUST CORP | $1 051 133 | 371 425 | 0,63% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $985 366 | 348 186 | 0,59% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $915 955 | 323 659 | 0,55% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $854 422 | 301 916 | 0,51% | Acciones |
| XTX Topco Ltd | $820 658 | 289 985 | 0,49% | Acciones |
| MORGAN STANLEY | $746 479 | 263 773 | 0,44% | Acciones |
| Invesco Ltd. | $586 701 | 207 315 | 0,35% | Acciones |
| IEQ CAPITAL, LLC | $501 017 | 177 038 | 0,30% | Acciones |
| D. E. Shaw & Co., Inc. | $459 900 | 162 509 | 0,27% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $370 659 | 130 975 | 0,22% | Acciones |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $367 900 | 130 000 | 0,22% | Acciones |
| FMR LLC | $367 736 | 129 942 | 0,22% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $357 539 | 126 339 | 0,21% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347 524 | 122 800 | 0,21% | Acciones |
| BARCLAYS PLC | $344 042 | 121 570 | 0,21% | Acciones |
| Qube Research & Technologies Ltd | $341 889 | 120 809 | 0,20% | Acciones |
| MACKENZIE FINANCIAL CORP | $325 985 | 115 189 | 0,19% | Acciones |
| Bank of New York Mellon Corp | $324 978 | 114 833 | 0,19% | Acciones |
| JANE STREET GROUP, LLC | $315 899 | 111 625 | 0,19% | Acciones |
| Point72 Asset Management, L.P. | $302 261 | 106 806 | 0,18% | Acciones |
| Man Group plc | $283 133 | 100 047 | 0,17% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $268 428 | 94 851 | 0,16% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $233 922 | 82 658 | 0,14% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 presentaciones | 19 de mayo de 2026 | 4,90% | Enmienda | Inversión pasiva | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Srinivas Akkaraju ×4 presentaciones | 24 de noviembre de 2025 | 4,90% | Enmienda | · | SEC |
| LSP 6 Management B.V., LSP 6 Holding C.V., LSP 6 NK Holding B.V ×3 presentaciones | 12 de febrero de 2025 | 4,00% | Enmienda | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×3 presentaciones | 29 de marzo de 2024 | · | Presentación inicial | · | SEC |
| Novo Holdings A/S ×4 presentaciones | 3 de junio de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 10 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Paul J Hastings | Chief Executive Officer | 18 de junio de 2026 S | 390 247 | 0 | 2 | $-58 728 |
| Matthew Plunkett | Chief Financial Officer | 9 de julio de 2020 A | · | 0 | 0 | $0 |
| Nadir Mahmood | President | 15 de enero de 2026 S | 167 727 | 0 | 1 | $-11 693 |
| Shawn Marshall Rose | Chief Medical Officer, Head of Research & Development | 6 de enero de 2026 A | 70 000 | 0 | 0 | $0 |
| Alyssa Levin | Chief Financial and Business Officer | 15 de enero de 2025 S | 102 662 | 0 | 0 | $0 |
| David Shook | Chief Medical Officer, Head of Research & Development | 15 de enero de 2025 S | 190 955 | 0 | 0 | $0 |
| Ralph Brandenberger | Chief Technical Officer | 15 de enero de 2025 S | 124 796 | 0 | 0 | $0 |
| Alicia J. Hager | Chief Legal Officer | 15 de enero de 2025 S | 146 735 | 0 | 0 | $0 |
| James Trager | Chief Scientific Officer | 18 de junio de 2024 S | 150 959 | 0 | 0 | $0 |
| Kanya Rajangam | Chief Medical Officer | 14 de enero de 2022 A | 12 800 | 0 | 0 | $0 |
| George Vratsanos | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Zachary Scheiner | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Angela Thedinga | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Michael Dybbs | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Simeon George | Consejero | 10 de junio de 2026 A | 451 659 | 0 | 0 | $0 |
| Leone D Patterson | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Fouad Oscar Azzam | Consejero | 7 de junio de 2023 A | · | 0 | 0 | $0 |
| Tiba Aynechi | Consejero | 8 de junio de 2022 A | · | 0 | 0 | $0 |
| Laura Shawver | Consejero | 8 de junio de 2022 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| Peter W. Sonsini | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 14 de julio de 2020 C | 2 793 865 | 0 | 0 | $0 |
| Forest Baskett | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| Scott D. Sandell | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| Joshua Makower | Propietario del 10% | 14 de julio de 2020 C | 2 902 115 | 0 | 0 | $0 |
| GSK plc | · | 14 de julio de 2020 A | 3 150 732 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 17 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 80 111 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,03% | 149 326 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 38 962 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 101 133 SH | 2 de octubre de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 1 123 160 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 21 336 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 145 492 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 3 413 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 031 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17 065 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8 973 SH | 3 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 599 527 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 567 021 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 259 168 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 786 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 6 442 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 452 090 SH | 11 de septiembre de 2026 | Diario |
NKTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$10.50
+307,8%
4 30,8%
Compra fuerte
8 61,5%
Compra
1 7,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
6 analistas · 2026-10-03Objetivo medio $10.83 +320,7%
← Por Debajo de Todos los Objetivos
Precio Actual $2.58
Mín$9.00
Media$10.83
Máx$14.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026